TY - JOUR
T1 - Basic Science and Pathogenesis
AU - Dehghani, Nadia
AU - Chen, Qijun
AU - Wadhwani, Anil R.
AU - Goldberg, David C.
AU - Jin, Jin
AU - Sreepada, Lasya P.
AU - Leone, Isabella
AU - Jala, Angelina
AU - Wolk, David A.
AU - Lee, Eddie B.
AU - Farrell, Kurt
AU - Crary, John F.
AU - Zhou, Wanding
AU - Johnson, F. Bradley
AU - McMillan, Corey T.
AU - Group, Part Working
N1 - Publisher Copyright:
© 2025 The Alzheimer's Association. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
PY - 2025/12/1
Y1 - 2025/12/1
N2 - BACKGROUND: Telomeres are repetitive DNA sequences at the ends of chromosomes which contribute to maintaining chromosomal stability. Telomere shortening is a hallmark of aging and shorter blood leukocyte telomere length (LTL) has been associated with increased risk for age-related diseases, however, little is understood about the biology of brain telomeres and how they may be involved in disease. Considering the increased neuropathologic burden of phosphorylated tau (ptau) with age, we investigated how shorter brain telomere length (brain-TL) may relate to increased ptau burden. METHODS: We studied a cohort of 112 individuals with primary age-related tauopathy (PART), a neuropathological diagnosis characterized by mild-to-moderate tau burden (Braak=I-IV) primarily in the medial temporal lobe, with the relative absence of amyloid-beta plaques (CERAD=0). These individuals had both brain-TL (mean length by telomere qPCR, blinded) and DNA methylation measures from the frontal cortex, along with semi-quantitative Aperio ptau measures from the hippocampus. A subset (n = 81) had SNP genotyping data available. In an independent cohort (n = 10, Braak=0-VI, CERAD=0-3), we performed quantitative fluorescence in-situ hybridization (FISH) microscopy to measure the average ratio of telomere to centromere DNA content in nuclei from the frontal and visual cortices. RESULTS: In linear regression models, frontal cortex brain-TL did not relate to age. When age-adjusted, shorter brain-TL related to higher hippocampal ptau (β=-1.06, CI=-1.92--0.195, p = 0.017). A previously established DNA methylation model predictive of hippocampal ptau partially mediated the relationship between brain-TL and hippocampal ptau (proportion mediated=0.664, CI=0.246-1.33, p = 0.012, Figure 1). A polygenic score for LTL did not relate to either age, brain-TL or hippocampal ptau. With FISH, we observed that individuals with CERAD=0 had shorter telomeres in the frontal cortex compared to individuals with CERAD=3. Within the CERAD=0 group, an individual with Braak=II had shorter telomeres than an individual with Braak=I. These patterns were not observed in the visual cortex. CONCLUSIONS: In a PART cohort, shorter frontal cortex brain-TL was related to higher hippocampal ptau, and this relationship was partially mediated by a DNA methylation model predictive of hippocampal ptau. A polygenic score for LTL was not predictive of brain-TL or hippocampal ptau. Together, this further emphasizes the importance of tissue-specific epigenetic modifiers of age-related ptau neuropathology.
AB - BACKGROUND: Telomeres are repetitive DNA sequences at the ends of chromosomes which contribute to maintaining chromosomal stability. Telomere shortening is a hallmark of aging and shorter blood leukocyte telomere length (LTL) has been associated with increased risk for age-related diseases, however, little is understood about the biology of brain telomeres and how they may be involved in disease. Considering the increased neuropathologic burden of phosphorylated tau (ptau) with age, we investigated how shorter brain telomere length (brain-TL) may relate to increased ptau burden. METHODS: We studied a cohort of 112 individuals with primary age-related tauopathy (PART), a neuropathological diagnosis characterized by mild-to-moderate tau burden (Braak=I-IV) primarily in the medial temporal lobe, with the relative absence of amyloid-beta plaques (CERAD=0). These individuals had both brain-TL (mean length by telomere qPCR, blinded) and DNA methylation measures from the frontal cortex, along with semi-quantitative Aperio ptau measures from the hippocampus. A subset (n = 81) had SNP genotyping data available. In an independent cohort (n = 10, Braak=0-VI, CERAD=0-3), we performed quantitative fluorescence in-situ hybridization (FISH) microscopy to measure the average ratio of telomere to centromere DNA content in nuclei from the frontal and visual cortices. RESULTS: In linear regression models, frontal cortex brain-TL did not relate to age. When age-adjusted, shorter brain-TL related to higher hippocampal ptau (β=-1.06, CI=-1.92--0.195, p = 0.017). A previously established DNA methylation model predictive of hippocampal ptau partially mediated the relationship between brain-TL and hippocampal ptau (proportion mediated=0.664, CI=0.246-1.33, p = 0.012, Figure 1). A polygenic score for LTL did not relate to either age, brain-TL or hippocampal ptau. With FISH, we observed that individuals with CERAD=0 had shorter telomeres in the frontal cortex compared to individuals with CERAD=3. Within the CERAD=0 group, an individual with Braak=II had shorter telomeres than an individual with Braak=I. These patterns were not observed in the visual cortex. CONCLUSIONS: In a PART cohort, shorter frontal cortex brain-TL was related to higher hippocampal ptau, and this relationship was partially mediated by a DNA methylation model predictive of hippocampal ptau. A polygenic score for LTL was not predictive of brain-TL or hippocampal ptau. Together, this further emphasizes the importance of tissue-specific epigenetic modifiers of age-related ptau neuropathology.
UR - https://www.scopus.com/pages/publications/105025836814
U2 - 10.1002/alz70855_105996
DO - 10.1002/alz70855_105996
M3 - Article
C2 - 41444799
AN - SCOPUS:105025836814
SN - 1552-5260
VL - 21
SP - e105996
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
ER -